REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 202 filers reported holding REATA PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $14,557,000 | +19.7% | 117,758 | -5.7% | 0.01% | -7.7% |
| Q3 2020 | $12,161,000 | -39.3% | 124,834 | -2.8% | 0.01% | -45.8% |
| Q2 2020 | $20,036,000 | +0.0% | 128,418 | -7.5% | 0.02% | -31.4% |
| Q1 2020 | $20,034,000 | -31.2% | 138,797 | -2.5% | 0.04% | +2.9% |
| Q4 2019 | $29,109,000 | +94.7% | 142,390 | -23.5% | 0.03% | +54.5% |
| Q3 2019 | $14,949,000 | -13.9% | 186,191 | +1.2% | 0.02% | +57.1% |
| Q2 2019 | $17,353,000 | +51.4% | 183,919 | +37.1% | 0.01% | -12.5% |
| Q1 2019 | $11,462,000 | – | 134,105 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Conrad N. Hilton Foundation | 63,481 | $7,847,000 | 100.00% |
| CPMG Inc | 2,896,901 | $358,115,000 | 55.16% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 140,000 | $17,307,000 | 26.62% |
| Corriente Advisors, LLC | 525,000 | $64,901,000 | 15.45% |
| DUMAC, INC. | 76,050 | $9,401,000 | 7.33% |
| MADDEN SECURITIES Corp | 35,152 | $4,345,000 | 2.80% |
| Biondo Investment Advisors, LLC | 113,692 | $14,055,000 | 2.69% |
| Duquesne Family Office | 749,897 | $92,702,000 | 2.50% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $3,754,000 | 2.44% |
| Integral Health Asset Management, LLC | 50,000 | $6,181,000 | 1.84% |